Kura Oncology is a biopharmaceutical company based in Cambridge, MA, specializing in the development of precision medicines for the treatment of cancer. The company focuses on identifying and targeting specific genetic mutations that drive the growth of cancer cells.
Through innovative research and clinical trials, Kura Oncology aims to bring new treatment options to patients with advanced or hard-to-treat cancers. Their mission is to improve outcomes and quality of life for individuals affected by cancer.
Generated from their business information